Back
Yelp Vs. Monopar Therapeutics Industry Stock Comparison
Buy
61
YELP
Yelp
Last Price:
$36.98
Seasonality Move:
19.16%
Buy
58
MNPR
Monopar Therapeutics
Last Price:
$38.04
Seasonality Move:
-27.37%
Buy
58
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.11. The Score for MNPR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
YELP Stock Price Chart
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
YELP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 46.89 | Sell |
Chaikin Money Flow: | -21550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.18 - 39.52) | Sell |
Bollinger Bands (100): | (34.65 - 39.39) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.92 | Sell |
Relative Strength Index (14 RSI): | 52.39 | Buy |
Chaikin Money Flow: | -19687 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.06 - 40.2) | Buy |
Bollinger Bands (100): | (31.46 - 43.3) | Sell |
YELP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.69 | Sell |
20-day SMA: | 38.5 | Sell |
50-day SMA: | 36.5 | Buy |
200-day SMA: | 36.47 | Buy |
8-day EMA: | 37.48 | Sell |
20-day EMA: | 37.59 | Sell |
50-day EMA: | 37.06 | Sell |
200-day EMA: | 36.99 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.68 | Buy |
20-day SMA: | 35.35 | Buy |
50-day SMA: | 37.26 | Sell |
200-day SMA: | 25.41 | Buy |
8-day EMA: | 35.09 | Buy |
20-day EMA: | 35.67 | Buy |
50-day EMA: | 36.42 | Buy |
200-day EMA: | 27.7 | Buy |
Yelp Earnings Growth & YELP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.22 per share, and an increase next year of $0.28 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.11 per share.
Yelp Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |